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Introduction {#sec1}
============

Long non-coding RNAs (lncRNAs) are an important class of transcripts, with the length longer than 200 nt, which participates in various physiological processes, such as immune surveillance, post-translational regulation, cell differentiation, proliferation, apoptosis, and epigenetic regulation. Especially, accumulating studies have indicated that a large number of lncRNAs are involved in numerous complex human diseases, such as various cancers ([@bib6], [@bib30]), blood diseases ([@bib7], [@bib1], [@bib20]), and neurodegeneration diseases ([@bib12]). Therefore, inferring the potential association between lncRNA and disease is helpful to understand the pathogenesis of complex diseases at the molecular level and provide new insights into the diagnosis, treatment, and prognosis of diseases.

Profit from the development of high-throughput experimental techniques, such as Microarray, Northern blots and qPCR, Fluorescence *in situ* hybridization, RNA interference, and RNA immunoprecipitation ([@bib25]), a large amount of data about lncRNAs-disease associations have been determined and distributed in different public databases, such as lncRNAdb ([@bib2]), NRED ([@bib9]), and NONCODE ([@bib23]). However, although experimentally validated lncRNA-disease associations drive research and development of medical molecular biology, they often have high false positives and false negatives. Moreover, many experimental methods are expensive and time-consuming. Consequently, it is essential to develop a computational prediction approach based on the accumulated biological data to accurately and rapidly find potential lncRNAs-disease associations. Computational method can quantitatively describe the associations between lncRNAs and diseases and efficiently screen out the most promising lncRNA-disease association pairs for further biological experimental validation.

The proposed computational method for predicting lncRNA-disease association can be roughly divided into three categories. Methods in the first category uncover ncRNA-disease associations based on the idea of network or link prediction. The underlying assumption is that lncRNAs associated with the same or similar diseases are more likely to have similar functions. Liao et al. constructed a coding-non-coding gene co-expression network based on public microarray expression profiles to discover the potential functions of lncRNA ([@bib15]). Yang et al. applied a propagation algorithm to predict lncRNA-disease associations by constructing a coding-non-coding gene-disease bipartite network based on known associations between diseases and disease-causing genes ([@bib26]). Chen et al. came up with the model called IRWRLDA to identify potential associations by integrating known lncRNA-disease associations, disease semantic similarity, and various lncRNA similarity measures ([@bib5]). Huang et al. proposed a model called PBMDA to predict microRNA (miRNA)-disease associations by integrating known human miRNA-disease associations, miRNA functional similarity, disease semantic similarity, and Gaussian interaction profile kernel similarity ([@bib28]). Methods in the second category utilize matrix factorization to identify potential lncRNA-disease associations. The basic assumption is that unknown association information can be derived from other known association information. Fu et al. predicted lncRNA-disease associations by decomposing data matrices of heterogeneous data sources into low-rank matrices ([@bib10]). Lu et al. developed a method called SIMCLDA for potential lncRNA-disease association prediction based on inductive matrix completion ([@bib16]). These two types of methods are based on specific assumptions, but these assumptions are not unanimously accepted. Relevant studies have shown that in many cases bio macromolecules with similar structures or ligands do not have the same functions. Matrix factorization approaches will experience dramatic performance degradation when the known associated information is insufficient. In addition, these methods both cannot mine the similarity feature of lncRNA and disease, and consider the inherent logic of the association between lncRNA and disease from the perspective of data-driven. Machine learning models are used in the third category to discover the unknown lncRNA-disease associations. Lan et al. proposed a method called LDAP to identify latent associations between lncRNAs and diseases by using a bagging support vector machine (SVM) classifier based on lncRNA similarity and disease similarity ([@bib13]). Since these methods are the beginning of machine learning application for lncRNA-disease association prediction, there is still much room for improvement in the prediction performance, prediction accuracy of such methods can be still greatly improved by increasing training samples and using more appropriate and advanced learning algorithms. Recently, the accumulation of association data between lncRNA and disease and the development of machine learning technology provide a better opportunity for predicting the association between lncRNA and disease using supervised learning model.

Instead of using network-based and matrix factorization-based methods to compute association scores directly, we explored to extract association features from lncRNA-disease pairs by multiple similarity matrices and trained machine learning models in a supervised manner to predict their association. In this study, we proposed a novel supervised computational method named (LDASR) for large-scale lncRNA-disease association prediction based on collaborative filtering and machine learning technologies. First, the feature vectors of the lncRNA-disease pairs were obtained by integrating lncRNA functional similarity, disease semantic similarity, and Gaussian interaction profile kernel similarity. Second, autoencoder neural network was employed to low the feature dimension and get the optimal feature subspace from the original feature set. Finally, considering the size of training samples and the possible non-linear relationship in input, we trained rotating forest to carry out prediction of LncRNA-Disease Association. The flow of LDASR is represented in [Figure 1](#fig1){ref-type="fig"}. In leave-one-out cross-validation (LOOCV) and five cross-validation to evaluate test data, the proposed LDASR model achieved better results than some previous methods, with AUC of 0.9502 and 0.9428, respectively. The test results show that supervised learning model can achieve better performance.Figure 1Flowchart of LDASRStep 1: Building three similarity matrices for disease by combining semantic information and Gaussian kernel information. Step 2: Building 1 similarity matrix for lncRNA. Step 3: Extraction of similarity feature vectors for disease and lncRNA from disease similarity matrix and lncRNA similarity matrix. Step 4: Extracting the same number of positive and negative samples from the adjacency matrix to construct the dataset used in this paper. Step 5: Selecting the most valuable features and reducing feature noise by using autoencoder. Step 6: more discriminant feature vectors were put into Rotation Forest ensemble classifier for training, verification, and prediction. The construction of disease semantic matrix can see also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Results {#sec2}
=======

Leave-One-Out Cross-Validation {#sec2.1}
------------------------------

For LOOCV, each sample in the dataset is selected for testing in turn, and the remaining samples are used as the training set to construct the prediction model. As we have mentioned, 1,765 lncRNA-disease associations, which have been experimental verified, were regarded as positive samples. Then we randomly picked 1,765 lncRNA-disease associations in the remaining associations as negative samples. The total number of datasets was 3,530, so we trained and tested 3,530 times according to the LOOCV method to get the final experimental result. At the same time, we drew ROC (receiver operating characteristic curve) and calculated AUC (area under curve) under LOOCV as shown in [Figure 2](#fig2){ref-type="fig"} to quantify the prediction results and facilitate comparison with other methods. For LOOCV, LDASR obtained AUCs of 0.9502, indicating that the model combining various similarities and rotation forest had a strong ability to distinguish the difference between positive and negative samples.Figure 2The ROC and AUC of LDASR in LOOCV Based on the v2017 Dataset (3,530 lncRNA-Disease Associations)

Five-fold Cross-Validation {#sec2.2}
--------------------------

For 5-fold cross-validation, the entire dataset is randomly divided into five mutually exclusive subsets of roughly equal size, each of which is used in turn as a test set for evaluation, and the remaining four subsets served as training sets to build the model. To better verify the performance of our method and save computing resources, LDASR was further evaluated by 5-fold cross-validation. For 5-fold cross-validation, LDASR obtained mean AUC of 0.9428 in the end as shown in [Figure 3](#fig3){ref-type="fig"}.Figure 3The ROCs and AUCs of LDASR in 5-Fold Cross-validation Based on the v2017 Dataset (3,530 lncRNA-Disease Associations)

To more comprehensively evaluate our model, we used a broader range of evaluation criteria, including accuracy (Acc.), sensitivity (Sen.), specificity (Spec.), precision (Prec.), and MCC. The prediction performance is listed in [Table 1](#tbl1){ref-type="table"}. The results of average Acc., Sen., Spec., Prec., MCC, and AUC were 85.72%, 90.14%, 81.31%, 82.86%, 71.74%, and 94.28% when using the proposed method to predict lncRNA-disease associations. The standard deviations of these values were 1.59%, 0.77%, 2.69%, 2.11%, 3.05%, and 0.94%, respectively. For 5-fold cross-validation shown in [Figure 5](#fig5){ref-type="fig"}, LDASR obtained high mean AUC of 0.9428. The high AUCs showed that LDASR combining multiple similarities and rotation forest was feasible and effective to predict lncRNA disease associations. At the same time, the lower standard deviation of these standards implied that the proposed model was robust and stable.Table 1Five-fold Cross-validation Results Performed by LDASR on the v2017 Dataset (3,530 lncRNA-Disease Associations)FoldAcc. (%)Sen. (%)Spec. (%)Prec. (%)MCC (%)AUC (%)083.8590.0877.6280.1068.2493.11185.2788.9581.5982.8570.7393.19284.4289.8079.0481.0769.2494.78388.1091.2284.9985.8776.3595.27486.9790.6583.2984.4374.1495.08**Average85.72 ± 1.5990.14 ± 0.7781.31 ± 2.6982.86 ± 2.1171.74 ± 3.0594.28 ± 0.94**

Compared with Other Classifiers {#sec2.3}
-------------------------------

To assess the performance of Rotation Forest: In this section, we compared Rotation Forest with several common classifiers in 5-fold cross-validation, including Random Forest, Logistic Regression, Naive Bayes, and SVM. To be fair, all settings except classifiers are default and the same dataset is used. The ROC curves implemented by five classifiers are summarized in [Figure 4](#fig4){ref-type="fig"}. As seen in [Figure 4](#fig4){ref-type="fig"}, it is obvious that the Rotation Forest achieves the best results. The effectiveness mainly has the following factors: (1) Based on the idea of collaborative filtering, there might be cases of non-independence between feature attributes generated by the similarity between lncRNA and disease. This affects the predictive capability of Naive Bayes. (2) The performance of the SVM classifier is more sensitive to data. Proper selection of the parameters and the correct choice of the kernel function will result in a large training cost. (3) The prediction performance of the logistic regression is limited by the assumption that the feature and the target must be linearly separable, so the lower AUC was obtained. (4) Tree-based assemble algorithms such as Random Forest and Rotating Forest are not affected by the nonlinear relationships in the data, so they have achieved excellent results in the five-fold cross-validation. Compared with the Random Forest, Rotating forest randomly combines the sample attribute sets before each subsample is extracted, and Principal Component Analysis (PCA) is utilized to transform the data between the divided sets of sub-attributes. This operation not only makes each sub-sample different, but also plays a certain role in data pre-processing, thereby improving the accuracy and difference of each base classifier to obtain excellent assemble effect.Figure 4Comparison with Random Forest, Logistic Regression, Naive Bayes, and SVM in 5-Fold Cross-validation Based on the v2017 Dataset (3,530 lncRNA-Disease Associations)

Compared with Other Methods {#sec2.4}
---------------------------

The LDASR was further tested by comparing it with other three state-of-the-art methods involving LRLSLDA ([@bib4]), LRLSLDA-LNCSIM1 ([@bib3]), and LRLSLDA-LNCSIM2 ([@bib3]). The comparison of the obtained AUC between LDASR and previous methods in LOOCV is shown in [Figure 5](#fig5){ref-type="fig"}. The results on 2012v dataset showed obviously that our proposed method made some progress. As a result, the proposed method achieved 0.1013, 0.0643, and 0.0575 improvements in terms of AUC compared with other three approaches in terms of AUC under LOOCV. Because the Leave-one-out cross-validation uses one observation as the validation set and the remaining observations as the training set, the model under LOOCV will always be a very stable solution. Therefore, it was difficult to add error bars to [Figure 5](#fig5){ref-type="fig"}. Compared with traditional computational methods for the prediction of lncRNAs-diseases associations, machine learning can consider similarity information from the perspectives of probability, statistics, approximation, and convex analysis and iteratively and optimally grasp the essential associations rule between RNA and disease. And this data-driven approach will show a stronger advantage as data are accumulated. The improved prediction performance produced by this method further validates the potential of machine learning algorithms on such problems. Although 5% does not seem to be a considerable improvement, we hope to draw the attention of relevant researchers and open a novel perspective on solving problems by machine learning strategies.Figure 5Under the v2012 Dataset (586 lncRNA-Disease Associations), LDASR and LRLSLDA, LRLSLDA-LNCSIM1, LRLSLDA-LNCSIM2 Were Compared between the AUCs Obtained under LOOCV

Case Study {#sec2.5}
----------

To evaluate the capability of the model in practical application, we applied LDASR to predict Colorectal Cancer, Glioma, and Prostate cancer as two kinds of case studies. For the purpose of simulating the real environment and ensuring the fairness of case studies, the associations of LncRNADisease database (v2017) were used to train the model and the remaining four additional databases, including Lnc2Cancer ([@bib19]), MNDR ([@bib8]), CRlncRNA ([@bib21]), and LncRNAWiki ([@bib17]), were used to verify the results.

For the first kind of case study, Colorectal Cancer was chosen as the research subject. In this case study, all 1,765 associations in LncRNADisease database (v2017) were used as positive samples. The negative samples of the same size as positive samples are generated by random selection in the rest. Therefore, the test set was constructed by connecting colorectal cancer diseases to all lncRNAs in the other three databases, respectively. As a result, a total of 881 lncRNA-colorectal cancer pairs were verified as test samples. Finally, samples with a predicted probability greater than 0.5 are screened out and sorted according to the probability values from large to small. Recent results in biological experiments confirmed that Colorectal Cancer was related to gene XIST ([@bib14]), AB073614 ([@bib24], [@bib22]), and SNHG3 ([@bib11]). They were all in the top of the list, but they were not included in the LncRNADisease database. Then, we ranked all the 881 lncRNAs based on their predicted association scores and validated the top 10 lncRNAs in LncRNADisease, CRlncRNA, MNDR 2.0, and Lnc2Cancer. The results are shown in the [Table 2](#tbl2){ref-type="table"}.Table 2Top 10 Colorectal Cancer-Associated lncRNAs Predicted by LDASRNumlncRNAConfirmed Database1snhg3LncRNAWiki2linc00237Unconfirmed3kcna2Unconfirmed4xistLncRNADisease/MNDR 2.05cahmLncRNADisease/CRlncRNA6bx649059LncRNADisease/CRlncRNA/MNDR 2.07ab073614Lnc2Cancer8bx648207LncRNADisease/CRlncRNA/MNDR 2.09ak123657LncRNADisease/CRlncRNA/MNDR 2.010fas-as1Unconfirmed

In the second kind of case study, Glioma and Prostate Cancer were the subjects of the study. A glioma is a tumor that begins with glial cells in the brain or spine ([@bib18]). The experimental design for case study 2 is as follows: For positive sample set, we removed all Glioma-related associations in the positive sample set. There were 42 positive samples related to Glioma here, so the number of positive samples was 1,723. Like case study 1, we used the same method to select 1,723 negative samples and 881 test samples. The test sample set was put into the classifier after training with positive and negative samples. In the end, we found that XIST and CYTOR were both at the top of the list, but they were not included in the LncRNADisease database. Recent results in biological experiments confirmed that Glioma was related to XIST ([@bib27]) and CYTOR ([@bib29]). Then, we ranked all the 881 lncRNAs based on their predicted association scores and validated the top 10 lncRNAs in LncRNADisease, CRlncRNA, MNDR 2.0, and Lnc2Cancer. The results can be seen in [Table 3](#tbl3){ref-type="table"}.Table 3Top 10 Glioma-Associated lncRNAs Predicted by LDASRNumlncRNAConfirmed Database1zfat-as1Unconfirmed2xistCRlncRNA/MNDR 2.03spry4-it1LncRNADisease/CRlncRNA/MNDR 2.04cytorMNDR 2.05neat1LncRNADisease/CRlncRNA6meg3LncRNADisease/CRlncRNA7malat1LncRNADisease/CRlncRNA/MNDR 2.08cdkn2b-as1LncRNADisease9h19LncRNADisease/CRlncRNA10hotairLncRNADisease/CRlncRNA/MNDR 2.0

For Prostate Cancer, all the experimental steps are the same as Glioma. For the positive sample set, we removed all Prostate Cancer-related associations in the positive sample set. There were 55 positive samples related to Glioma here, so the number of positive samples was 1,710. Like case study Glioma, we used the same method to select 1,710 negative samples and 881 test samples. The list of the validated top 10 lncRNAs are listed in [Table 4](#tbl4){ref-type="table"}.Table 4Top 10 Prostate Cancer-Associated lncRNAs Predicted by LDASRNumlncRNAConfirmed Database1pcat29LncRNADisease/CRlncRNA/MNDR 2.02tug1Unconfirmed3malat1LncRNADisease/CRlncRNA/MNDR 2.04hif1a-as2Unconfirmed5h19LncRNADisease/CRlncRNA6dleu1LncRNADisease/MNDR 2.07dgcr5Unconfirmed8cytorUnconfirmed9cdkn2b-as3Unconfirmed10cdkn2b-as11LncRNADisease/CRlncRNA/MNDR 2.0/Lnc2Cancer

Discussion {#sec3}
==========

Accumulating evidences have highlighted the positive role of developing a powerful machine-learning-based method to predict potential associations between lncRNAs and diseases, which could significantly help people to understand the pathogenesis of complex diseases at the molecular level and provide new insights into the diagnosis, treatment, and prognosis of diseases. In this paper, we proposed a novel computational method, LDASR, to predict the unknown lncRNA-disease associations by integrating multiple similarity information. Compared with previous methods, we embed this task into a machine learning framework to better understand the essential law of the association between lncRNA and diseases. First, we extracted feature vectors for lncRNA and disease from multiple similarity matrices and constructed the feature vector of RNA-disease pairs by connecting features of lncRNA to that of disease. Then, autoencoder neural network was employed to reduce the feature dimension and improve the efficiency and accuracy of classifier. Finally, we applied rotation forest to carry out prediction. LDASR first shows its good performance by LOOCV and 5-fold cross-validation experiments. Furthermore, the comparison test shows that LDASR has a powerful prediction ability to distinguish positive and negative samples, which is obviously better than the other state-of-the-art methods. Finally, the analyses of case studies further prove that LDASR holds significant value in inferring potential lncRNA-disease associations in practice. As a novel computational method, it is anticipated that LDASR has potential value in biomedical research for comprehending the pathogenesis of diseases, which can further advance the quality of disease diagnostics, therapy, prognosis, and prevention. As a novel computational approach, LDASR could not only play a positive role in rapidly understanding the pathogenesis of disease and improving the quality of disease diagnosis, treatment, prognosis, and prevention but also confirms the great potential of machine learning in predicting the relationship between RNA and disease.

Limitations of the Study {#sec3.1}
------------------------

There are several limitations in the current model. First, in the stage of characterizing lncRNA, we hope to fully combine and utilize a variety of information such as the sequence of lncRNA in the future instead of using only the Gaussian Interaction Profile Kernel Similarity. Second, Gaussian Interaction Profile Kernel Similarity is a traditional network representation learning method widely used in the embedding of bipartite graph nodes. With the rise of deep learning, novel network representation learning methods emerge in an endless stream, which can more effectively characterize the behavior of nodes and the structure of the entire network. We hope to take advantage of deep learning to improve prediction ability in the future. Third, all parameters are default in the process of constructing the model, and we believe that the performance of models can achieve a visible progress through the adjustment of the parameters.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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